Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Saved in:
| Title: | Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial. |
|---|---|
| Authors: | Pergola PE; Renal Associates, P.A., San Antonio, Texas., Devalaraja M; Corvidia Therapeutics, Inc., Waltham, Massachusetts., Fishbane S; Division of Nephrology, Department of Medicine, Donald and Barbara Zucker School of Medicine, Great Neck, New York., Chonchol M; Division of Renal Medicine Disease and Hypertension, University of Colorado, Aurora, Colorado., Mathur VS; Mathur Consulting, Woodside, California., Smith MT; Nephrology Associates, Augusta, Georgia., Lo L; Corvidia Therapeutics, Inc., Waltham, Massachusetts., Herzog K; Corvidia Therapeutics, Inc., Waltham, Massachusetts., Kakkar R; Pandion Therapeutics, Inc., Waltham, Massachusetts., Davidson MH; Corvidia Therapeutics, Inc., Waltham, Massachusetts. |
| Source: | Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2021 Jan; Vol. 32 (1), pp. 211-222. Date of Electronic Publication: 2020 Dec 03. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1533-3450 |
|---|---|
| DOI: | 10.1681/ASN.2020050595 |
